Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy
Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy
复制标题
与接受蒽环类化疗的日本乳腺癌患者帕洛诺司琼、阿瑞匹坦和地塞米松止吐效果相关的遗传风险因素
DOI：
10.1016/j.clbc.2017.05.013
复制
发表时间：
2017
影响因子：
3.1
通讯作者：
Ooi K
中科院分区：
文献类型：
--
作者：
Yokoyama S;Tamaru S;Tamaki S;Nakanishi D;Mori A;Yamakawa T;Ao T;Sakata Y;Mizuno T;Iwamoto T;Watanabe K;Simomura M;Kawakami K;Konishi N;Kageyama S;Ohtani S;Yamada T;Ban S;Ooi K
